Cancer patients develop acute kidney injury (AKI) due to malignancy or its treatment. Chemotherapeutic agents, particularly those that are nephrotoxic, play a significant role in the development of AKI. Additionally, factors such as tumor lysis syndrome, obstructive uropathy from tumor invasion, and sepsis contribute to renal impairment. AKI can lead to prolonged hospitalization, increased morbidity, and compromised treatment efficacy. Therefore, early identification and management of AKI are crucial in cancer patients.
To gain more insights on “Acute Kidney Injury in Oncology,” join renowned Nephrologist Dr. Georgi Abraham in our informative World Kidney Cancer Day special webinar on 20 th June 2024 , 3:00 PM IST onwards . Stay Tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no…
